Literature DB >> 21716053

Implications of weight-based stigma and self-bias on quality of life among individuals with schizophrenia.

Jessica A Barber1, Laura Palmese, Erin L Reutenauer, Carlos M Grilo, Cenk Tek.   

Abstract

Obesity has been associated with significant stigma and weight-related self-bias in community and clinical studies, but these issues have not been studied among individuals with schizophrenia. A consecutive series of 70 obese individuals with schizophrenia or schizoaffective disorder underwent assessment for perceptions of weight-based stigmatization, self-directed weight bias, negative affect, medication compliance, and quality of life. The levels of weight-based stigmatization and self-bias were compared with levels reported for nonpsychiatric overweight/obese samples. Weight measures were unrelated to stigma, self-bias, affect, and quality of life. Weight-based stigmatization was lower than published levels for nonpsychiatric samples, whereas levels of weight-based self-bias did not differ. After controlling for negative affect, weight-based self-bias predicted an additional 11% of the variance in the quality of life measure. Individuals with schizophrenia and schizoaffective disorder reported weight-based self-bias to the same extent as nonpsychiatric samples despite reporting less weight stigma. Weight-based self-bias was associated with poorer quality of life after controlling for negative affect.

Entities:  

Mesh:

Year:  2011        PMID: 21716053      PMCID: PMC3135000          DOI: 10.1097/NMD.0b013e318221403d

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  22 in total

1.  Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.

Authors:  K Thompson; J Kulkarni; A A Sergejew
Journal:  Schizophr Res       Date:  2000-05-05       Impact factor: 4.939

2.  Subtyping binge eating disorder.

Authors:  C M Grilo; R M Masheb; G T Wilson
Journal:  J Consult Clin Psychol       Date:  2001-12

3.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

4.  Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Yael Ratner; Jean Endicott
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

Review 5.  Obesity in women.

Authors:  Leila Azarbad; Linda Gonder-Frederick
Journal:  Psychiatr Clin North Am       Date:  2010-06

6.  The spread of the obesity epidemic in the United States, 1991-1998.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

Review 7.  Negative affectivity: the disposition to experience aversive emotional states.

Authors:  D Watson; L A Clark
Journal:  Psychol Bull       Date:  1984-11       Impact factor: 17.737

8.  Obesity stigmatization and coping: relation to mental health symptoms, body image, and self-esteem.

Authors:  A Myers; J C Rosen
Journal:  Int J Obes Relat Metab Disord       Date:  1999-03

9.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

10.  Obesity as a risk factor for antipsychotic noncompliance.

Authors:  Peter J Weiden; Joan A Mackell; Diana D McDonnell
Journal:  Schizophr Res       Date:  2004-01-01       Impact factor: 4.939

View more
  6 in total

1.  Weight bias internalization and health: a systematic review.

Authors:  R L Pearl; R M Puhl
Journal:  Obes Rev       Date:  2018-05-22       Impact factor: 9.213

Review 2.  A scoping review of weight bias by community pharmacists towards people with obesity and mental illness.

Authors:  Andrea L Murphy; David M Gardner
Journal:  Can Pharm J (Ott)       Date:  2016-06-06

3.  A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.

Authors:  Cenk Tek; Joseph Ratliff; Erin Reutenauer; Rohan Ganguli; Stephanie S O'Malley
Journal:  J Clin Psychopharmacol       Date:  2014-10       Impact factor: 3.153

4.  Health and health-related quality of life among treatment-seeking overweight and obese adults: associations with internalized weight bias.

Authors:  Janet D Latner; Laura E Durso; Jonathan M Mond
Journal:  J Eat Disord       Date:  2013-01-22

Review 5.  Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review.

Authors:  Benedicto Crespo-Facorro; Jose Maria Pelayo-Teran; Jacqueline Mayoral-van Son
Journal:  Neurol Ther       Date:  2016-08-23

6.  'It's common sense that an individual must eat': Advocating for food justice with people with psychiatric disabilities through photovoice.

Authors:  Lara Carson Weinstein; Mariana Chilton; Renee Turchi; Ann C Klassen; Marianna LaNoue; Alexis Silvero; Leopoldo J Cabassa
Journal:  Health Expect       Date:  2020-07-15       Impact factor: 3.377

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.